The "Start-up and You" will focus on agreements between the start-up and the individual at a stage of company formation after patent applications have been filed and investors are interested, but before the technology is licensed to the start-up or investor money has been received.
Jeff Wiesen, one of the country’s leading biotechnology lawyers, has retired from his law firm but, as an MIT alum, is keen to be involved with the Koch Institute and MIT Community.
Jeff has been involved in the biotech industry representing biotech companies since 1979, when he helped organize Biogen and negotiated its ground-breaking collaboration with Schering Plough. He specialized in licensing and collaborations, venture capital transactions and acquisitions. He has been listed as a leading national life sciences lawyer and a leading Massachusetts corporate/M&A lawyer since 2004 in the Chambers Guide to America’s Leading Lawyers for Business.
Hosted by the Koch Institute for Integrative Cancer Research